Product Description
Artemether-Lumefantrine is a classic Artemisinin Combination Therapy (ACT). Artemether rapidly kills malaria parasites at the erythrocytic stage and relieves fever quickly; Lumefantrine eliminates residual parasites, prevents recurrence and reduces drug resistance. Oral suspension has good flavor, easy administration, especially suitable for infants, children and patients who cannot take tablets. It complies with WHO malaria treatment guidelines.
Indications
- Treatment of uncomplicated Plasmodium falciparum malaria
- First-line ACT medicine for adults and pediatric patients
- Malaria treatment in malaria-endemic regions
Administration
Shake well before use. Take orally with food or fatty drink to improve absorption. Dosage by body weight, follow full 3-day standard course as medical instruction or WHO protocol.
Product Features
- Fixed dose: Artemether 180mg + Lumefantrine 1080mg
- WHO recommended first-line ACT antimalarial
- Fast fever clearance + low recurrence rate
- Suspension form, friendly for children
- Low resistance, high safety and well tolerance
Storage
Store sealed in cool dry place, protect from light. After reconstitution, refrigerate, avoid freezing and use within shelf time.
Warnings
- Prescription antimalarial, use under medical supervision.
- Contraindicated in hypersensitivity to artemether, lumefantrine or excipients.
- Must finish full treatment course to prevent relapse and drug resistance.
- Caution in pregnancy, lactation and severe liver dysfunction.
- Keep out of reach of children.
